NCT06252792View on ClinicalTrials.gov

Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

June 15, 2024

Primary Completion Date

June 15, 2025

Study Completion Date

June 15, 2026

Conditions
Multiple MyelomaFirst Relapse
All Listed Sponsors
collaborator

Affiliated Hospital of Hebei University

OTHER

collaborator

Second Hospital of Shanxi Medical University

OTHER

collaborator

Shandong Cancer Hospital and Institute

OTHER

collaborator

First Affiliated Hospital of Jinan University

OTHER

collaborator

Sun Yat-sen University

OTHER

lead

FengYan Jin

OTHER

NCT06252792 - Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma | Biotech Hunter | Biotech Hunter